These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23327570)

  • 21. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
    Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
    J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 24. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is "COMET" pointing in the right direction?--Pro].
    Hanrath P
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2666. PubMed ID: 14673747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 27. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
    Askari H; Semizel E; Bostan OM; Cil E
    Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
    Rohrer CK; Page RL; Shakar SF; Lindenfeld J
    J Card Fail; 2011 Oct; 17(10):875-7. PubMed ID: 21962427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
    Si D; Wang J; Xu Y; Chen X; Zhang M; Zhou H
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol.
    Can Fam Physician; 1999 May; 45():1199-202, 1205-9. PubMed ID: 10349064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.
    Spaeder J; Najjar SS; Gerstenblith G; Hefter G; Kern L; Palmer JG; Gottlieb SH; Kasper EK
    Am Heart J; 2006 Apr; 151(4):844.e1-10. PubMed ID: 16569544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
    Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
    Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter by Banach et al regarding article, "postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting".
    Banach M; Mariscalco G; Ugurlucan M; Rysz J
    Circ J; 2008 Aug; 72(8):1388; author reply 1389. PubMed ID: 18654032
    [No Abstract]   [Full Text] [Related]  

  • 38. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
    Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.
    Black-Maier E; Steinberg BA; Piccini JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):627-36. PubMed ID: 25959096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.